Redefining Diagnosis and Management in Hepatology with Multiparametric Ultrasound

With the increasing global prevalence of steatotic liver disease (SLD), there is a growing demand for fast, accurate, and low-cost diagnostic methods. This interview summarises the insights of expert gastroenterologists who participated in a series of videos focusing on the evolving global prevalence of liver disease. Alina Popescu, Felix Bende, Roxana Sirli, and Ioan Sporea, Department of Gastroenterology and Hepatology, Victor Babeș University of Medicine and Pharmacy, Timișoara, Romania, shared their clinical insight and recommendations regarding best-practice diagnosis and assessment using multiparametric ultrasound technology. They highlighted gold-standard recommendations for the diagnosis of liver diseases, the advantages and limitations of different diagnostic approaches, and emphasised the importance of early diagnosis and intervention to prevent metabolic dysfunction-associated steatotic liver disease (MASLD) from progressing to its most severe form of the disease, metabolic dysfunction-associated steatohepatitis (MASH). Each expert explored a patient case study from their clinical practice, navigating patient presentation, real-world assessment, and outcomes when using a high mid-range AI-powered multiparametric ultrasound system (LOGIQ Totus™, GE HealthCare), a recent advancement in diagnostic ultrasound for liver disease.